BCD-020

rituximab biosimilar · Biocad

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BCD-020, covering 2017-03-27 to 2017-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma [Phase 3]